Skip to Main Content

Paper Details

Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma.
Mol Cancer Ther
18
2020
Author NameAffiliation
Lianbo YuComprehensive Cancer Center, The Ohio State University
Lianbo YuThe Ohio State University
  • 1 - 2

Datasets

Release 1.2